Rapamycin-d3
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Rapamycin-d3
UNSPSC Description:
Rapamycin-d3 is the deuterium labeled Rapamycin. Rapamycin is a potent and specific mTOR inhibitor with an IC50 of 0.1 nM in HEK293 cells. Rapamycin binds to FKBP12 and specifically acts as an allosteric inhibitor of mTORC1. Rapamycin is an autophagy activator, an immunosuppressant[1][2].Target Antigen:
Autophagy; FKBP; mTORType:
Isotope-Labeled CompoundsRelated Pathways:
Apoptosis;Autophagy;Cell Cycle/DNA Damage;Immunology/Inflammation;PI3K/Akt/mTORApplications:
Cancer-Kinase/proteaseField of Research:
CancerPurity:
95.48Solubility:
DMSO : 110 mg/mL (ultrasonic)Smiles:
O=C([C@@]1(O[C@@H](CC[C@H]1C)C[C@@H](/C(C)=C/C=C/C=C/[C@H](C2)C)OC([2H])([2H])[2H])O)C(N3[C@@H](CCCC3)C(O[C@@H](CC([C@@H](/C=C([C@H]([C@H](C([C@@H]2C)=O)OC)O)\C)C)=O)[C@@H](C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)=O)=OMolecular Weight:
917.19References & Citations:
[1]Edwards SR, et al. The rapamycin-binding domain of the protein kinase mammalian target of rapamycin is a destabilizing domain. J Biol Chem, 2007, 282(18), 13395-13401.|[2]Rangaraju S, et al. Rapamycin activates autophagy and improves myelination in explant cultures from neuropathicmice. J Neurosci. 2010 Aug 25;30(34):11388-97.Shipping Conditions:
Blue IceStorage Conditions:
-20°C, 3 years (Powder)Clinical Information:
No Development ReportedCAS Number:
392711-19-2
